Investigating how a specific receptor in mast cells affects skin inflammation and defense mechanisms.
Roles of novel MRGPRX2/MrgprB2 signaling in mast cells on host defense and Inflammation
This study is looking at how a specific receptor in immune cells helps fight off bacterial infections and control inflammation, especially for people with skin conditions like rosacea, to find new ways to treat these issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10745330 on NIH RePORTER |
What this research studies
This research focuses on the role of the MRGPRX2 receptor in mast cells, which are crucial for the body's immune response. It explores how this receptor interacts with antimicrobial peptides to help clear bacterial infections and regulate inflammation, particularly in conditions like rosacea. The study involves both human and mouse models to understand the signaling pathways and mechanisms involved in mast cell activation and its implications for skin disorders. By examining these processes, the research aims to uncover potential therapeutic targets for managing skin diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from rosacea or related skin disorders.
Not a fit: Patients with skin conditions unrelated to mast cell activation or those not experiencing inflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for skin conditions like rosacea by targeting specific signaling pathways in mast cells.
How similar studies have performed: Previous research has shown promising results in understanding mast cell signaling and its implications for skin diseases, indicating that this approach has potential for success.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Ali, Hydar — University of Pennsylvania
- Study coordinator: Ali, Hydar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.